Annual CAPEX
$453.10 K
-$1.62 M-78.15%
31 December 2023
Summary:
Cumberland Pharmaceuticals annual capital expenditures is currently $453.10 thousand, with the most recent change of -$1.62 million (-78.15%) on 31 December 2023. During the last 3 years, it has fallen by -$1.66 million (-78.57%). CPIX annual CAPEX is now -94.01% below its all-time high of $7.56 million, reached on 31 December 2013.CPIX CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$47.90 K
+$1100.00+2.35%
30 September 2024
Summary:
Cumberland Pharmaceuticals quarterly capital expenditures is currently $47.90 thousand, with the most recent change of +$1100.00 (+2.35%) on 30 September 2024. Over the past year, it has dropped by -$47.20 thousand (-49.63%). CPIX quarterly CAPEX is now -99.26% below its all-time high of $6.51 million, reached on 30 June 2006.CPIX Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$239.60 K
-$47.20 K-16.46%
30 September 2024
Summary:
Cumberland Pharmaceuticals TTM capital expenditures is currently $239.60 thousand, with the most recent change of -$47.20 thousand (-16.46%) on 30 September 2024. Over the past year, it has dropped by -$1.77 million (-88.06%). CPIX TTM CAPEX is now -96.83% below its all-time high of $7.56 million, reached on 31 December 2013.CPIX TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CPIX CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -78.2% | -49.6% | -88.1% |
| 3 y3 years | -78.6% | -55.7% | -50.7% |
| 5 y5 years | -89.4% | -73.4% | -92.9% |
CPIX CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -78.6% | +27.8% | -97.1% | +14.3% | -89.1% | at low |
| 5 y | 5 years | -89.4% | +27.8% | -97.1% | +14.3% | -92.9% | at low |
| alltime | all time | -94.0% | +237.9% | -99.3% | +115.3% | -96.8% | +454.6% |
Cumberland Pharmaceuticals CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $47.90 K(+2.4%) | $239.60 K(-16.5%) |
| June 2024 | - | $46.80 K(-19.6%) | $286.80 K(-14.8%) |
| Mar 2024 | - | $58.20 K(-32.9%) | $336.80 K(-25.7%) |
| Dec 2023 | $453.10 K(-78.2%) | $86.70 K(-8.8%) | $453.10 K(-77.4%) |
| Sept 2023 | - | $95.10 K(-1.8%) | $2.01 M(-5.8%) |
| June 2023 | - | $96.80 K(-44.5%) | $2.13 M(-3.4%) |
| Mar 2023 | - | $174.50 K(-89.4%) | $2.21 M(+6.4%) |
| Dec 2022 | $2.07 M(+485.0%) | $1.64 M(+650.9%) | $2.07 M(+304.7%) |
| Sept 2022 | - | $218.50 K(+26.6%) | $512.40 K(+27.4%) |
| June 2022 | - | $172.60 K(+311.9%) | $402.10 K(+44.6%) |
| Mar 2022 | - | $41.90 K(-47.2%) | $278.00 K(-21.6%) |
| Dec 2021 | $354.50 K(-83.2%) | $79.40 K(-26.6%) | $354.40 K(-27.1%) |
| Sept 2021 | - | $108.20 K(+123.1%) | $486.30 K(-67.7%) |
| June 2021 | - | $48.50 K(-59.0%) | $1.51 M(-9.2%) |
| Mar 2021 | - | $118.30 K(-44.0%) | $1.66 M(-21.4%) |
| Dec 2020 | $2.11 M(+107.4%) | $211.30 K(-81.3%) | $2.11 M(-6.4%) |
| Sept 2020 | - | $1.13 M(+459.5%) | $2.26 M(+72.6%) |
| June 2020 | - | $201.90 K(-64.7%) | $1.31 M(+9.1%) |
| Mar 2020 | - | $571.20 K(+61.0%) | $1.20 M(+17.7%) |
| Dec 2019 | $1.02 M(-76.2%) | $354.70 K(+96.7%) | $1.02 M(-69.6%) |
| Sept 2019 | - | $180.30 K(+94.1%) | $3.36 M(-16.8%) |
| June 2019 | - | $92.90 K(-76.3%) | $4.03 M(-0.1%) |
| Mar 2019 | - | $391.20 K(-85.5%) | $4.04 M(-5.5%) |
| Dec 2018 | $4.28 M(+187.1%) | $2.69 M(+213.5%) | $4.28 M(+107.7%) |
| Sept 2018 | - | $858.60 K(+785.2%) | $2.06 M(+56.3%) |
| June 2018 | - | $97.00 K(-84.5%) | $1.32 M(-14.4%) |
| Mar 2018 | - | $627.80 K(+32.3%) | $1.54 M(+3.4%) |
| Dec 2017 | $1.49 M(-30.1%) | $474.50 K(+303.8%) | $1.49 M(-0.3%) |
| Sept 2017 | - | $117.50 K(-63.2%) | $1.49 M(-20.6%) |
| June 2017 | - | $319.10 K(-44.8%) | $1.88 M(-6.5%) |
| Mar 2017 | - | $577.90 K(+20.8%) | $2.01 M(-5.6%) |
| Dec 2016 | $2.13 M(-21.1%) | $478.40 K(-5.2%) | $2.13 M(+14.4%) |
| Sept 2016 | - | $504.70 K(+12.2%) | $1.86 M(+78.2%) |
| June 2016 | - | $450.00 K(-35.5%) | $1.05 M(-14.8%) |
| Mar 2016 | - | $698.00 K(+232.1%) | $1.23 M(-54.6%) |
| Dec 2015 | $2.70 M | $210.20 K(-167.2%) | $2.70 M(-32.3%) |
| Sept 2015 | - | -$313.00 K(-149.6%) | $3.99 M(-24.6%) |
| June 2015 | - | $631.30 K(-70.9%) | $5.29 M(+5.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2015 | - | $2.17 M(+45.1%) | $5.02 M(+53.7%) |
| Dec 2014 | $3.26 M(-56.8%) | $1.50 M(+51.5%) | $3.26 M(-50.8%) |
| Sept 2014 | - | $988.00 K(+173.1%) | $6.64 M(+3.0%) |
| June 2014 | - | $361.80 K(-13.5%) | $6.44 M(-7.4%) |
| Mar 2014 | - | $418.50 K(-91.4%) | $6.96 M(-8.0%) |
| Dec 2013 | $7.56 M(+198.0%) | $4.87 M(+513.0%) | $7.56 M(+128.1%) |
| Sept 2013 | - | $793.90 K(-9.5%) | $3.31 M(-11.3%) |
| June 2013 | - | $876.90 K(-14.2%) | $3.74 M(+11.7%) |
| Mar 2013 | - | $1.02 M(+64.3%) | $3.35 M(+31.9%) |
| Dec 2012 | $2.54 M(+479.4%) | $622.00 K(-48.9%) | $2.54 M(+28.8%) |
| Sept 2012 | - | $1.22 M(+150.8%) | $1.97 M(+100.2%) |
| June 2012 | - | $485.00 K(+127.1%) | $984.20 K(+64.9%) |
| Mar 2012 | - | $213.60 K(+284.9%) | $596.80 K(+36.3%) |
| Dec 2011 | $437.80 K(-43.0%) | $55.50 K(-75.9%) | $437.70 K(-38.1%) |
| Sept 2011 | - | $230.10 K(+135.8%) | $707.50 K(-0.9%) |
| June 2011 | - | $97.60 K(+79.1%) | $713.70 K(-6.0%) |
| Mar 2011 | - | $54.50 K(-83.2%) | $759.10 K(-1.2%) |
| Dec 2010 | $768.60 K(+7.9%) | $325.30 K(+37.7%) | $768.70 K(-13.2%) |
| Sept 2010 | - | $236.30 K(+65.2%) | $885.10 K(+10.8%) |
| June 2010 | - | $143.00 K(+123.1%) | $799.10 K(+7.3%) |
| Mar 2010 | - | $64.10 K(-85.5%) | $744.60 K(+4.5%) |
| Dec 2009 | $712.30 K(+431.2%) | $441.70 K(+193.9%) | $712.40 K(+153.3%) |
| Sept 2009 | - | $150.30 K(+69.8%) | $281.20 K(+77.4%) |
| June 2009 | - | $88.50 K(+177.4%) | $158.50 K(+32.2%) |
| Mar 2009 | - | $31.90 K(+203.8%) | $119.90 K(-10.6%) |
| Dec 2008 | $134.10 K(-18.0%) | $10.50 K(-62.0%) | $134.10 K(-35.9%) |
| Sept 2008 | - | $27.60 K(-44.7%) | $209.10 K(-3.8%) |
| June 2008 | - | $49.90 K(+8.2%) | $217.40 K(+22.3%) |
| Mar 2008 | - | $46.10 K(-46.1%) | $177.80 K(+8.7%) |
| Dec 2007 | $163.50 K(-97.5%) | $85.50 K(+138.2%) | $163.50 K(+223.1%) |
| Sept 2007 | - | $35.90 K(+248.5%) | $50.60 K(+15.5%) |
| June 2007 | - | $10.30 K(-67.6%) | $43.80 K(-99.3%) |
| Mar 2007 | - | $31.80 K(-216.1%) | $6.54 M(-0.2%) |
| Dec 2006 | $6.55 M(+1957.4%) | -$27.40 K(-194.2%) | $6.55 M(-0.4%) |
| Sept 2006 | - | $29.10 K(-99.6%) | $6.58 M(+0.4%) |
| June 2006 | - | $6.51 M(>+9900.0%) | $6.55 M(>+9900.0%) |
| Mar 2006 | - | $43.20 K | $43.20 K |
| Dec 2005 | $318.50 K | - | - |
FAQ
- What is Cumberland Pharmaceuticals annual capital expenditures?
- What is the all time high annual CAPEX for Cumberland Pharmaceuticals?
- What is Cumberland Pharmaceuticals annual CAPEX year-on-year change?
- What is Cumberland Pharmaceuticals quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Cumberland Pharmaceuticals?
- What is Cumberland Pharmaceuticals quarterly CAPEX year-on-year change?
- What is Cumberland Pharmaceuticals TTM capital expenditures?
- What is the all time high TTM CAPEX for Cumberland Pharmaceuticals?
- What is Cumberland Pharmaceuticals TTM CAPEX year-on-year change?
What is Cumberland Pharmaceuticals annual capital expenditures?
The current annual CAPEX of CPIX is $453.10 K
What is the all time high annual CAPEX for Cumberland Pharmaceuticals?
Cumberland Pharmaceuticals all-time high annual capital expenditures is $7.56 M
What is Cumberland Pharmaceuticals annual CAPEX year-on-year change?
Over the past year, CPIX annual capital expenditures has changed by -$1.62 M (-78.15%)
What is Cumberland Pharmaceuticals quarterly capital expenditures?
The current quarterly CAPEX of CPIX is $47.90 K
What is the all time high quarterly CAPEX for Cumberland Pharmaceuticals?
Cumberland Pharmaceuticals all-time high quarterly capital expenditures is $6.51 M
What is Cumberland Pharmaceuticals quarterly CAPEX year-on-year change?
Over the past year, CPIX quarterly capital expenditures has changed by -$47.20 K (-49.63%)
What is Cumberland Pharmaceuticals TTM capital expenditures?
The current TTM CAPEX of CPIX is $239.60 K
What is the all time high TTM CAPEX for Cumberland Pharmaceuticals?
Cumberland Pharmaceuticals all-time high TTM capital expenditures is $7.56 M
What is Cumberland Pharmaceuticals TTM CAPEX year-on-year change?
Over the past year, CPIX TTM capital expenditures has changed by -$1.77 M (-88.06%)